Feb. 26, 2007 — Maquet Critical Care announced its has received FDA 510(k) clearance for its breakthrough NAVA (Neurally Adjusted Ventilatory Assist) technology for optional use with the company’s SERVO-i ventilator. The SERVO-i ventilator with NAVA option is intended for treatment and monitoring of all patients, neonatal, pediatric and adults who require mechanical ventilation.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now